Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Fulvestrant
Sponsor: Dana-Farber Cancer Institute
Collaborators: Beth Israel Deaconess Medical Center|Massachusetts General Hospital|Lowell General Hospital|Brigham and Women's Hospital